Interferon for hepatitis C patients with psychiatric disorders

Am J Psychiatry. 2004 Dec;161(12):2332; author reply 2332-4. doi: 10.1176/appi.ajp.161.12.2332.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Bipolar Disorder / chemically induced
  • Comorbidity
  • Drug Therapy, Combination
  • Hepatitis C / drug therapy*
  • Hepatitis C / epidemiology
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use*
  • Mental Disorders / epidemiology*
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / therapeutic use
  • Substance Withdrawal Syndrome / etiology

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a